Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
This Quarter Return
+5.31%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$23B
AUM Growth
+$23B
(-1%)
Cap. Flow
+$484M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
616
Reduced
448
Closed
86
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.24B |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$68.3M |
| 3 |
Apple
AAPL
|
$59.4M |
| 4 |
Itron
ITRI
|
$53.5M |
| 5 |
Eagle Materials
EXP
|
$49.9M |
Top Sells
| 1 |
Cooper Companies
COO
|
$77.4M |
| 2 |
Adobe
ADBE
|
$71.4M |
| 3 |
Microsoft
MSFT
|
$66.3M |
| 4 |
Nasdaq
NDAQ
|
$38.6M |
| 5 |
Abbott
ABT
|
$37.6M |
Sector Composition
| 1 | Technology | 36.8% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.13% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $1.48B | 6.43% | 3,309,631 -148,292 | -4% | -$66.3M |
|
|
2
Apple
AAPL
$3.45T
| $1.39B | 6.03% | 6,587,827 +282,184 | +4% | +$59.4M |
|
|
3
NVIDIA
NVDA
$4.24T
| $1.38B | 6.01% | 11,191,891 +9,997,497 | +837% | +$1.24B |
|
4
Eli Lilly
LLY
$657B
| $686M | 2.98% | 758,099 -37,511 | -5% | -$34M |
|
5
Alphabet (Google) Class A
GOOGL
$2.57T
| $523M | 2.27% | 2,871,441 -113,824 | -4% | -$20.7M |
|
6
Meta Platforms (Facebook)
META
$1.86T
| $517M | 2.25% | 1,025,923 +23,148 | +2% | +$11.7M |
|
7
Broadcom
AVGO
$1.4T
| $514M | 2.23% | 319,968 +26,328 | +9% | +$42.3M |
|
|
8
Alphabet (Google) Class C
GOOG
$2.58T
| $461M | 2% | 2,512,460 -149,614 | -6% | -$27.4M |
|
9
UnitedHealth
UNH
$281B
| $442M | 1.92% | 868,050 +28,615 | +3% | +$14.6M |
|
10
Merck
MRK
$210B
| $268M | 1.16% | 2,162,580 +269,554 | +14% | +$33.4M |
|
11
Mastercard
MA
$538B
| $257M | 1.12% | 583,332 -42,307 | -7% | -$18.7M |
|
12
JPMorgan Chase
JPM
$829B
| $249M | 1.08% | 1,229,060 +24,751 | +2% | +$5.01M |
|
13
Thermo Fisher Scientific
TMO
$186B
| $216M | 0.94% | 390,661 -20,745 | -5% | -$11.5M |
|
14
Johnson & Johnson
JNJ
$427B
| $216M | 0.94% | 1,474,927 +95,735 | +7% | +$14M |
|
15
Intuit
INTU
$186B
| $198M | 0.86% | 301,871 -8,973 | -3% | -$5.9M |
|
|
16
Vertex Pharmaceuticals
VRTX
$100B
| $195M | 0.85% | 416,381 +145,696 | +54% | +$68.3M |
|
17
AbbVie
ABBV
$372B
| $194M | 0.84% | 1,129,124 -50,261 | -4% | -$8.62M |
|
18
Berkshire Hathaway Class B
BRK.B
$1.09T
| $185M | 0.8% | 454,668 -4,885 | -1% | -$1.99M |
|
19
Edwards Lifesciences
EW
$47.8B
| $173M | 0.75% | 1,869,977 +292,134 | +19% | +$27M |
|
|
20
Abbott
ABT
$231B
| $168M | 0.73% | 1,615,463 -362,321 | -18% | -$37.6M |
|
21
Visa
V
$683B
| $146M | 0.64% | 557,848 -27,926 | -5% | -$7.33M |
|
22
Procter & Gamble
PG
$368B
| $138M | 0.6% | 837,802 -50,898 | -6% | -$8.39M |
|
23
Amgen
AMGN
$155B
| $136M | 0.59% | 435,990 +20,247 | +5% | +$6.33M |
|
24
TSMC
TSM
$1.2T
| $133M | 0.58% | 765,000 +46,000 | +6% | +$8M |
|
25
Jack Henry & Associates
JKHY
$11.9B
| $132M | 0.58% | 797,200 -42,000 | -5% | -$6.97M |
|